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1. Introduction
Aerobic organisms have evolved a range of 
mechanisms through which to achieve the optimal 
utilization of atmospheric oxygen (O
2
). In this well-
controlled system, the availability of O
2
 is the most 
critical issue, but it has become increasingly clear that 
other, less prominent components of the gaseous 
environment are also of importance to the cellular 
homeostasis. The discovery of nitric oxide (NO) as 
a signaling mediator radically altered the view of the 
roles and functions of gases in physiology, and the 
endogenous generation of carbon monoxide (CO) and 
hydrogen sulfide (H
2
S) by the mammalian cell further 
deepened the knowledge on the in vivo significance of 
gaseous products. The research on ‘gasotransmitter’ 
candidates and derivatives has been intensified, and 
this is currently a topic of pronounced scientific 
interest. Not surprisingly, new family members with 
new effects were proposed, leading to the listing of 
four essential characteristics (simplicity, availability, 
volatility and effectiveness) and the definition of six 
criteria that make a gas physiologically important or 
irreplaceable [1]. The aim of this paper is to discuss 
the available literature data on methane (CH
4
) from 
these aspects [2].
Criterion 1. ‘Gasotransmitters are small gas molecules 
dissolved in biological milieu’
Methane is a small, omnipresent, volatile molecule, 
the most hydrogen-substituted form of carbon. It plays 
a distinguished role in the tropospheric and strato-
spheric chemistry, where the bulk of the released CH
4
 
is oxidized to CO
2
 through its reaction with hydroxyl 
radicals (formed by the photoreaction between ozone 
and water vapor) [3, 4]. It should be noted that the bio-
activity or toxicity of the gas mediators NO, CO and 
H
2
S is related to their tendency to react with biologi-
cally important molecules. Nevertheless, CH
4
 is intrin-
sically nontoxic in vivo. The inhalation of normoxic air 
containing 2.5% CH
4
 for 3 h has been shown to have 
no side-effects on the blood gas chemistry and not to 
influence the macrohemodynamics in unstressed ani-
mals [5]. It is a simple asphyxiant, which means that tis-
sue hypoxia may occur when CH
4
 displaces the air and 
hence the O
2
 in a restricted space, and the concentra-
tion of O
2
 is reduced to below approximately 18% in the 
internal milieu of the body. On the other hand, CH
4
 can 
readily change the symbiosis with other gas molecules 
in closed spaces. The details and consequences of such 
in vivo relationships are basically unknown, because 
determination of the intracellular distribution of these 
gas molecules is technically limited.
AQ1
hkjjaviunva
M Boros al
Printed in the UK
506492
jbr
© 2015 IOP Publishing Ltd
2015
00
J. Breath Res.
JBR
1752-7163
000000
00
00
Journal of Breath Research
IOP
17
September
2014
16
November
2014
24
November
2014
2014
© 2015 IOP Publishing Ltd
The role of methane in mammalian physiology—is it a 
gasotransmitter?
Mihály Boros1, Eszter Tuboly1, András Mészáros1 and Anton Amann2,3
1 Institute of Surgical Research, Faculty of Medicine, University of Szeged, Szőkefalvi-Nagy B. u. 6, H-6720 Szeged, Hungary
2 Univ.-Clinic of Anesthesia and Critical Care Medicine, Innsbruck Medical University, Anichstr., 35, A-6020 Innsbruck, Austria
3 Breath Research Institute of the University of Innsbruck, Rathausplatz 4, A-6850 Dornbirn, Austria
E-mail: boros.mihaly@med.u-szeged.hu
Keywords: mammalian methanogenesis, nonmicrobial methane, mitochondrium, hypoxia 
Abstract
Mammalian methanogenesis is widely considered to be an exclusive sign of anaerobic microbial 
activity in the gastrointestinal tract. This commonly held view was challenged, however, when in 
vitro and in vivo investigations demonstrated the possibility of nonmicrobial methane formation in 
aerobic organisms, in plants and animals. The aim of this paper is to discuss the available literature 
data on the biological role of methane. When we evaluate the significance of methane generation 
in the mammalian physiology, the question may be examined: is it a gas mediator? Overall the data 
do not fully support the gasotransmitter concept, but they do support the notion that methane 
liberation may be linked to redox regulation and may be connected with hypoxic events leading to, or 
associated with a mitochondrial dysfunction. In this respect, the available information suggests that 
hypoxia-induced methane generation may be a necessary phenomenon of aerobic life, and perhaps a 
surviving evolutionary trait in the eukaryote cell.
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Only a few historical and contradictory data are 
available concerning the fate of CH
4
 in nonbacterial 
biological systems. No detectable utilization of inhaled 
CH
4
 was observed in healthy human volunteers [6], 
whereas 0.33% of intraarterially administered [14C]
CH
4
 was converted to [14C]CO
2
 in the sheep [7]. The 
importance of these observations is uncertain, but a 
recent study with a comprehensive data set demon-
strated high levels of oxidation and organic fixation 
of 14C originating from [14C]CH
4
 in many organs, and 
especially the liver, in rats [8]. It was proposed that 
interactions with free radical reactions could lead to a 
higher level of fixation and perhaps the oxidation of 
CH
4
 in a lipid environment, such as the mitochondrium 
membrane [8].
Criterion 2. ‘Gasotransmitters are freely permeable to 
membrane. As such, their intracellular and intercellular 
movements do not exclusively rely on cognate membrane 
receptors or other transportation machineries’
It is currently widely accepted that the bulk of the 
CH
4
 produced by anaerobic fermentation in the mam-
malian intestine is excreted via the lungs, and breath 
testing has therefore become a tool for the diagnosis of 
certain gastrointestinal (GI) conditions [9–14]. Never-
theless, as a consequence of its physicochemical proper-
ties, endogenous CH
4
 is distributed evenly across mem-
brane barriers, and traverses the mucosa and enters the 
splanchnic microcirculation freely. Thus, it should be 
considered that the production of CH
4
 is reflected not 
only in the exhaled air or in the flatus, but also in its pas-
sage through body surfaces. Indeed, the CH
4
 concentra-
tion in the breath is usually > 1 ppm in only 30–60% of 
humans [15], but a recent study revealed the release of 
~150 pg CH
4
 cm−2 in 30 min through the skin in healthy 
individuals, corresponding to 313 fmol cm−2 min−1 
[16]. This suggests that CH
4
 transported by the circu-
lating blood is excreted by the lungs only when a cer-
tain threshold is reached. For a perspective view of the 
release of CH
4
, this can be compared with the release 
through skin emanations of acetone (median release of 
~1100 fmol cm−2 min−1), acetaldehyde (a median release 
of ~250 fmol cm−2 min−1), 6-methyl-5-hepten-2-one 
(133 fmol cm−2 min−1; tentatively originating from oxi-
dative degradation of squalene), n-nonanal (a median 
release of ~60 fmol cm−2 min−1; tentatively originating 
from the oxidative degradation of oleic acid) or iso-
prene (a median release of ~5 fmol cm−2 min−1) [17].
Similarly, exogenous, inhaled CH
4
 will move from 
the alveoli into the circulation, diffusing into the 
plasma, throughout which it is distributed rapidly and 
evenly [18]. The solubility of CH
4
 in blood is rather 
low (a blood : air partition coefficient of 0.066) but the 
solubility in membrane bilayers is significantly higher 
(a partition coefficient of 0.20) [19, 20]. If there are no 
physical barriers to prevent its cellular entry, its con-
centration in all regions should be equal to the equi-
librium concentration in the atmosphere (where it is 
normally 1–2 ppb), or to that in the inhaled air or that 
within the lumen of the GI tract, if these are the sole or 
predominant sources of CH
4
. The fate of intracellular 
CH
4
 is an open question, but there are many hydropho-
bic and hydrophilic interfaces in the cytoplasm and CH
4
 
may enter the hydrophobic nonpolar lipid tails of the 
phospholipid biomembranes [21]. This effect will be 
even stronger at high salt concentrations, because the 
hydrophobic interactions are enhanced as a result of 
the salting-out effect [22, 23]. This entry should be tem-
porary, however, because, without a new supply, CH
4
 
will enter the circulation and then be excreted through 
the lungs if its partial pressure is higher than that in the 
atmosphere.
It follows that, if CH
4
 is taken up by the cells in the 
organism, it is able to target the cytosol or cell organelles 
freely. Moreover, CH
4
 may accumulate transiently at cell 
membrane interfaces, thereby transitorily changing the 
physicochemical properties or the in situ functionality 
of proteins, ion channels and receptors [24, 25] embed-
ded within this environment, and in this case it may 
influence the function of membrane-bound structures.
Criterion 3. ‘They are endogenously generated in 
mammalian cells with specific substrates and enzymes; 
more than the products of metabolism, their production is 
regulated to fulfill signaling messenger functions’
Abiotic, purely chemical routes at high tempera-
ture and/or elevated pressure are known to lead to CH
4
 
formation [26], but these reactions are unlikely under 
ambient in vivo conditions. Nevertheless, in the com-
plex ecosystem of the human GI tract, large amounts 
of CH
4
 can be produced by carbohydrate fermentation, 
during which CO
2
 is reduced to CH
4
 by the anaerobic 
metabolism of methanogenic microorganisms [27]. 
The catalyzing enzyme of this pathway is methyl co-
enzyme M reductase, while the microorganisms are the 
Archae, a phylogenetically independent group, well dis-
tinguished from the usual bacteria and the eukaryotes. 
Their clinically important feature is the lack of pepti-
doglycan in the cell wall, which makes them susceptible 
to certain antibiotics [28]. As an obligate anaerobe, this 
taxon requires a redox potential of less than −300 mV 
for growth, a condition that is present in the GI tract of 
mammals and in other anoxic environments (under-
water rice paddies or wetlands) [29]. The mamma-
lian methanogens can be divided into two groups: 
H
2
/CO
2
- and acetate-consumers, which are members of 
a microbial consortium, where methanogens obtain sub-
strates from higher levels, from H
2
-producers or aceto-
gens [30]. Methanogens are compelled to compete with 
other microorganisms, such as sulfate-reducing bacteria 
for the common substrates in the human colon [31].
The relevant human data are controversial, but CH
4
 
excretion is not detected in germ-free animals until 
shortly after they are contaminated with feces from a 
CH
4
-producing animal [32, 33]. CH
4
 breath testing in 
adults by means of lactulose ingestion reveals two dis-
tinct human populations, CH
4
-producers and nonpro-
ducers, production usually being defined as a >1 ppm 
increase above the atmospheric CH
4
 concentration 
[33]. The causes and consequences of this pattern are 
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subjects of debate and investigation; nevertheless, it is 
noteworthy that the proportion of CH
4
-producers has 
remained relatively stable in the western population 
during recent decades, despite changes in GI medica-
tion and diets [34].
Although mammalian methanogenesis is widely 
considered to be an exclusive indicator of microbio-
logical activity, in vitro and in vivo studies have also 
revealed the possibility of nonmicrobial CH
4
 formation 
in eukaryote cells, in plants and in animals [35–39]. As 
long ago as 2003, it was shown that hypoxia can lead to 
the generation of measurable amounts of nonbacterial 
CH
4
 in isolated mitochondria [40]. When the possible 
causes were explored, increasingly high amounts of 
CH
4
 were reproducibly generated after the addition of 
ascorbic acid and hydrogen peroxide (H
2
O
2
), and the 
formation was related linearly to the quantity of mito-
chondria incubated, the amount of H
2
O
2
 added and 
the pH of the reaction mixture [40]. Catalase, which 
decomposes H
2
O
2
, abolished the increase in CH
4
 pro-
duction, which indicated that mitochondrial H
2
O
2
 is 
required for the hypoxic activation of the CH
4
-gener-
ating reaction [40].
These findings were substantiated when Keppler 
et al provided direct evidence of aerobic CH
4
 genera-
tion in plants [35]. This key paper was followed by many 
plant studies that either supported or disagreed with the 
initial findings, but aerobic nonbacterial CH
4
 release 
was later clearly identified [41]. Many subsequent pub-
lications have confirmed the nonmicrobial CH
4
 release 
in cell cultures under various stress conditions [42–44]. 
More importantly, it has been shown that oxido-reduc-
tive stress or even physical injury elicits aerobic CH
4
 
emission [45]. These works were followed by a com-
prehensive study in which CH
4
 formation was detected 
in tobacco, grape vine and sugar beet cell cultures [38]. 
What was particularly interesting was that, under 
non-stress conditions, the cells produced only small 
amounts of CH
4,
 but the production was increased by 
one to two orders of magnitude when sodium azide 
(NaN
3
) was added to the cultures [38]. The main effect 
of NaN
3
 in plants is its direct and irreversible binding 
to the heme cofactor of cytochrome c oxidase, the final 
electron acceptor of the electron transport chain; thus, 
it can also be considered a tool via which to study mito-
chondrial oxido-reductive stress. Detailed overviews 
on CH
4
 generation in plants were presented by Keppler 
et al [46], and in the recent review by Wang et al [45] the 
emission of CH
4
 from plants is now clearly linked to a 
hitherto overlooked defense reaction.
In 2008, a study was undertaken which demon-
strated aerobic CH
4
 emission in cultured endothelial 
cells exposed to hypoxia and metabolic distress [47]. 
The latter included the inhibition of glucose uptake 
and anaerobic glycolysis, the application of site-spe-
cific inhibitors of the mitochondrial electron transport 
chain (NaN
3
 and NaCN), alone or in combination with 
glycolysis inhibitors, the application of an uncoupling 
agent, and treatment of the cells with increasing con-
centrations of the hydroxyl radical-generating Uden-
friend system (where the iron-catalyzed Fenton-type 
reaction between hydrogen peroxide and a transition 
metal is driven by ascorbate). These data provided 
clear evidence of stress-induced nonbacterial CH
4
 pro-
duction in eukaryotes [47]. The results revealed that 
a disturbance of the normal mitochondrial function 
led to significant CH
4
 generation in endothelial cells 
(~2–23 nmol mg−1 range), depending on the nature 
and intensity of the metabolic distress, and a similarly 
high and dose-dependent level of CH
4
 generation was 
measured after free-radical attack via the Udenfriend 
reaction.
In parallel with these studies, significant CH
4
 release 
was also demonstrated in whole animals under hypoxic 
stress conditions [37, 48], where changes in exhaled or 
released CH
4
 changes were detected in vivo. As a fur-
ther step, CH
4
 exhaled from the airways or discharged 
through the skin and body orifices was quantified by 
means of a whole-body CH
4
 detection setup using 
photoacoustic spectroscopy [39, 49]. The in vivo CH
4
 
production profile was determined after the induction 
of mitochondrial distress by chronic NaN
3
 admin-
istration, and the magnitude of the whole-body CH
4
 
emission was compared with that in rats treated with 
antibiotics to eradicate CH
4
-producing intestinal bac-
teria. The emanation of endogenous CH
4
 was detected 
throughout the 8 d experiments, and the inhibition of 
mitochondrial cytochrome c oxidase by chronic NaN
3
 
administration induced a significant level of CH
4
 gen-
eration, independently of the methanogenic flora [39].
Thus, the overall evidence from these findings sug-
gests that the excretion of CH
4
 in the breath in mam-
mals reflects not only intestinal bacterial fermentation, 
but also unidentified nonbacterial generation induced 
from target cells. In the setups involving NaN
3
 admin-
istration, the inhibition of complex IV could cause a 
rearrangement of the electron transport and result in 
the increased production of reactive oxygen species 
(ROS) at complexes II and III. It is therefore possible 
that the formation and constant build-up of ROS in 
the mitochondria are components of a reaction that 
furnishes CH
4
 in the living organism. As in plants, the 
release of CH
4
 may be associated with ROS generation 
after transient intracellular O
2
 deprivation [38, 39, 43, 
47], and may be an integral feature of cellular responses 
to changes in oxidative status in all eukaryotes.
2. Chemical processes leading to aerobic 
CH
4
 formation.
After the paper by Keppler et al describing the in 
situ formation of CH
4
 in plants, the accompanying 
editorial commentary asked what mechanism could be 
involved in the production of the fully hydrogenated 
gas CH
4
 in an oxidizing environment [35, 50]. Many 
publications are now available on the in vivo generation 
of CH
4
 under distinct pathophysiological conditions, 
but the exact mechanism of mammalian aerobic CH
4
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generation is basically unexplained, and at present a 
number of cellular sources are subjects of investigation. 
This is mainly due to the various possible sources and 
unknown reaction pathways that can be envisaged. 
However, as is evident from the following list, the 
common denominator of the different experimental 
setups has been hypoxia or ischemia and reperfusion 
with transient oxido-reductive stress.
 • The first hypothesis proposed the possible role 
of electrophilic methyl (CH
3
) group (EMG)-
containing biomolecules, leading to CH
4
 formation 
under reductive stress conditions [51]. It has been 
hypothesized that, if the sources of the CH
3
 groups 
are molecules such as phosphatidylcholine or 
S-adenosylmethionine, the substitution will lead to 
the generation of CH
4
. Mitochondrial experiments 
partially confirmed this theory (i.e. under highly 
reductive conditions, potentially electron acceptor 
biomolecules can be reduced, leading to the 
formation of CH
4
).
 • After the above hypothesis was forward, our 
research group identified CH
4
 formation in 
animal mitochondria [40]. To clarify the possible 
mechanism, an experimental setup was established 
which involved substances ubiquitously available 
in biotic systems, but without biological structures. 
In a chemical model reaction, the formation of CH
4
 
from choline was demonstrated in the presence of 
H
2
O
2
, catalytic iron (Fe3+) and ascorbic acid [40]. In 
this exothermic reaction, CO
2
 and CO are formed 
in parallel with CH
4
 generation. The components 
of the reaction mixture (other than uncomplexed 
iron) are known to be present in comparatively 
high concentrations in biological systems, but the 
in vivo significance of these chemical processes 
remained unknown. Thus, during the past 
decade other possible mechanisms have been 
proposed, with partial modification of the previous 
presumptions [44, 46, 47].
 • Through the use of simple buffers with 
compounds thought to be involved in aerobic 
CH
4
 formation, a ROS-generating Udenfriend 
system was established, which consisted of an 
EMG or CH
3
-donating compound (MDC)/
electron acceptor (e.g. choline chloride, betaine 
or phosphatidylcholine), reducing agents (e.g. 
ascorbate, NADH, NADPH, dithiothreitol or 
N-acetyl-L-cysteine), H
2
O
2
 and uncomplexed 
Fe3+ as catalyst. In this series of experiments, 
when the CH
4
-generating capacity of choline 
metabolites was tested, the amount of CH
4
 
formed was generally observed to increase 
linearly with the number of CH
3
 groups in the 
molecule (choline > 2,2-dimethylethanolamine > 
2-methylethanolamine > ethanolamine) [47].
 • Althoff et al proposed an alternative, but similar 
approach under more controlled conditions [52] 
for the aerobic formation of CH
4
 by the oxidation 
of ascorbic acid with iron compounds and H
2
O
2
. 
On the basis of experimental results with MDCs, 
methionine and methionine sulfoxide were used, 
which exhibited the highest CH
4
-formation ability, 
and the sulfur-bonded CH
3
 group in methionine 
was unambiguously identified by stable isotope 
labeling techniques as the carbon precursor of 
the CH
4
 molecule [53, 54]. These findings are in 
accordance with the concept of EMGs, which also 
explains the differences in CH
4
-formation ability 
between similar molecules. For example, although 
choline readily produces CH
4
, the analogous 
molecule betaine, which also contains an EMG, 
does not. In betaine, the nitrogen-bonded CH
3
 
group is sterically shielded and electrons are 
repelled by the electronegative N atom, reducing its 
reactivity.
 • In these model experiments, the highest level 
of CH
4
 formation was measured at around pH 
3.0 under hypoxic conditions, which can be 
explained at least partially by chemical reasons. 
Deprotonation of ascorbate ( =Kp 4. 37a ) leads 
to an acidic pH, at which the production of 
hydroxyl radicals is favored, unlike the situation 
at higher pH, where H
2
O
2
 produces nonreactive 
oxygen species [55]. A more thorough analysis 
of postulated reaction routes and detected and 
possible intermediates is to be found in Althoff ’s 
works [52–54].
 • A very similar process was described in plants 
[35, 36, 46]. CH
4
 release was reported from both 
fresh and dried foliage, in some cases after UV 
light irradiation. Later, pectin was shown to be 
the one of the origins of CH
4
, the carbon atom 
arising from the methoxy (CH
3
O) group. We 
refer here to an excellent review [45], in which 
the authors summarize the key characteristics 
of possible CH
4
-generating compounds, and in 
particular those involved in methanogenesis in 
plant cells.
 • The positive correlation between CH
4
 production 
and temperature (30–70 °C), the possibility of 
CH
4
 liberation from dried leaves and the heavily 
exothermic nature of the model reaction (up 
to 95 °C) suggested a chemical explanation 
rather than an enzymatic catalytic process [35, 
40]. Nevertheless, a modified reaction using 
methionine sulfoxide as substrate led to significant 
CH
4
 generation at ambient temperature [54]. In 
this chemical reaction, CH
4
 is readily formed from 
the S-CH
3
 groups of organosulfur compounds 
with tremendously varying yields, in a model 
system containing iron(II/III), H
2
O
2
 and ascorbate 
that uses organic compounds with heterobonded 
CH
3
 groups for the generation under ambient 
(1000 mbar and 22 °C) and aerobic (21% O
2
) 
conditions (figure 1).
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It should be added here that nonmicrobial CH
4
 
release from methionine has been confirmed in fungi 
under aerobic conditions [56] and methionine is 
known to be a key factor in many biochemical reac-
tions in plants, fungi and animals. Methionine residues 
in the surface of proteins are highly susceptibility to oxi-
dation, with the product generally being methionine 
sulfoxide, and it has been suggested that the suscep-
tibility to oxidation of proteins is proportional to the 
surface exposure of the methionine residues [57]. More 
importantly, the available data suggest that reversible 
methionine oxidation could be a novel mechanism 
in redox regulation, which involves the oxidation to 
methionine sulfoxide leading to an activated protein 
function [58]. The repair mechanism of methionine 
sulfoxide reductases (Msr) is capable of reducing the 
protein-bound methionine sulfoxide back to methio-
nine, in a stereospecific manner. It is noteworthy that 
cells lacking MsrA and MsrB genes are respiratory-defi-
cient due to lower levels of mitochondrial cytochrome 
c, and can have a shorter lifespan [59]. The in vivo gen-
eration of CH
4
 in association with the non-enzymatic 
methionine-methionine sulfoxide pathway or the 
methionine-Msr system has never been investigated, 
though it might be strongly relevant to the biochemis-
try and the role of biotic CH
4
 formation under oxida-
tive conditions ( figure 2). The in vivo role of choline or 
choline metabolites in endogenous methane formation 
is substantiated by the results showing that exogenous 
PC can suppress the methanogenic reaction [37]. Simi-
larly, when L-alpha-glycerylphosphorylcholine (GPC), 
a water-soluble, deacylated PC derivative was adminis-
tered in NaN
3
-induced chemical hypoxia, the extent of 
CH
4
 generation was reduced [39].
In summary, no direct enzymatic route of aero-
bic, nonbacterial biotic CH
4
 generation has yet been 
proven. Perhaps there is no need for it. If we consider 
the whole scale of the published in vitro findings, basi-
cally two postulations can be made. (1) A prerequisite of 
CH
4
 formation under ambient conditions is the avail-
ability of a donor compound containing one or more 
EMGs or MDCs or other related functional groups, and 
(2) a further prerequisite is the presence of oxidative or 
reductive stress (elevated reducing potential and radical 
reactions). It seems that various organic compounds 
can serve as the source of the liberated CH
4
. The com-
mon property of these molecules is the presence of a 
CH
3
 [54] or related group: CH
3
O [42, 46], CH
3
CO [44] 
or HOCH
2
 [42]. Practically ubiquitous compounds 
such as pectin, lignin, phospholipids, amino acids or 
even proteins may serve as depots of these functional 
groups. Another common feature of the chemical pro-
cesses explored so far is the presence of a highly reactive 
radical. However, the expanding literature on aerobic 
CH
4
 generation has not gone hand in hand with an 
understanding of the complexities of intracellular 
redox chemistry. Hydroxyl radicals can be produced 
in the iron-catalyzed Fenton or Haber–Weiss reactions 
during hypoxia and reoxygenation, and by virtue of its 
in situ reactivity this radical is able to break intramolec-
ular bonds in membranes, leading to the formation of 
CH
4
. Nevertheless, the data of Althoff et al suggested the 
critical role of a ferryl species ( = +[Fe O]IV 2 ) and methyl 
radicals, leading to the in vitro generation of CH
4
 from 
the starting methionine molecule [54]. This reaction 
route uses ferrihydrite, a biomimetic iron compound 
which releases Fe2+, maintaining a steady-state ion con-
centration. Most importantly, the process is theoreti-
cally relevant in vivo, since the inorganic core of ferritin 
is formed from ferrihydrite, and the generation of fer-
ryl species is commonly mediated by iron-containing 
oxygenases [60].
(4) ‘Gas mediators have well-defined specific functions at 
physiologically relevant concentrations, (5) the functions 
of endogenous gases can be mimicked by their exogenously 
applied counterparts and (6) they are involved in signal 
transduction and have specific cellular and molecular 
targets’.
In a discussion of these aspects of CH
4
 biology it 
should be born in mind that there is a conceptual differ-
ence between the baseline or physiological generation 
of a gas (e.g. NO, CO and H
2
S) and that after de novo 
induction or discordant alteration by inducer factors, 
and the affected processes or evolving responses may 
therefore be dependent on the number of molecules 
and/or the reactivity of the microenvironment. In this 
sense, the physiological levels of CH
4
 in the human 
body have not yet been determined. In general terms, 
about one-third of healthy individuals emit gaseous 
CH
4
 identified by breath testing [34], but the signifi-
cance of endogenous CH
4
 generation in the human 
body is still an open question.
Once generated by anaerobe microbes, or released 
by a nonbacterial process, CH
4
 is widely considered to 
be biologically inactive. However, some data do sug-
gest an association with the small bowel motility as the 
whole gut transit time is longer in human subjects who 
produce more CH
4
 than in those defined as nonpro-
ducers [11]. More directly, diarrheal conditions such as 
inflammatory bowel disease are negatively associated 
with CH
4
 production, and there is evidence that the 
production of CH
4
 as determined by breath testing is 
associated with delayed intestinal transit and constipa-
tion [13, 61]. Nevertheless, there are many inconsisten-
cies in human clinical investigations, and we refer here 
to a recent review in which the authors summarize the 
key characteristics of CH
4
-caused GI motility changes 
in humans, and in particular those which are clearly 
linked to bacterial methanogenesis [11].
Somewhat more straightforward data are avail-
able from experimental animal models. Using a physi-
ological model of peristalsis, Pimentel et al explored 
the effects of CH
4
 on the neuromuscular function in 
the guinea pig ileum [14]. Gassing the bath with CH
4
 
significantly increased the amplitude of contraction 
both orally and aborally in response to a stimulus. In a 
similar setup, luminal CH
4
 infusion reduced the transit 
time by an average of 59% in dogs, and thus it was there-
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fore hypothesized that CH
4
 activates a reflex pathway 
that leads to slowing in the proximal intestinal segment. 
Finally, it was concluded that CH
4
 may act as a neuro-
muscular transmitter, resulting in reduced propaga-
tion of the peristaltic movement in the intestine [14]. 
Another supportive study demonstrated that gaseous 
CH
4
 delayed the contraction velocity of peristalsis and 
increased the amplitude of peristaltic contractions in 
the guinea pig ileum in vitro [62]. Whether the infu-
sion of gases adequately mimics the physiologic set-
ting remains unknown, but another comprehensive 
study showed that the contractility of the intestinal 
muscles and/or their contraction rhythm were influ-
enced by CH
4
-induced decreases in the postprandial 
serotonin level [63]. Moreover, high levels of methano-
gen-produced CH
4
 were found in rats that consumed 
high-fat chow and also in obese human subjects, and 
the extent of colonization of methanogens in the GI 
tract of animals and humans was positively correlated 
to the development of obesity [64, 65]. Furthermore, a 
report is available where CH
4
 inhibited the contractile 
activity of the proximal colonic longitudinal muscle by 
activating the voltage-dependent potassium channels 
and increasing the voltage-dependent potassium cur-
rent of colonic smooth muscle cells in vitro [66]. Taken 
together, these data strongly suggest that CH
4
 might 
modulate the signaling activity of the enteric nervous 
system in both health and pathologies.
Nevertheless, exogenously applied CH
4
 has been 
shown to have other biological and/or signaling func-
tions in vitro and in vivo. Information on the cardio-
vascular effects of CH
4
 is sparse, but a historical paper 
reported an increased survival time in hemorrhaged 
rats after treatment with a CH
4
-air mixture [67]. It has 
additionally been shown that normoxic ventilation 
with 2.5% CH
4
 supplementation protects the tissues 
by mitigating the effects of an ischemia-reperfusion 
insult [5]. In this animal model, the levels of tissue 
ROS generation were reduced, the mesenteric vascu-
lar resistance changes were only moderate, and the 
intestinal pCO
2
 gap (a marker of the microcirculation) 
tended to normalize after reperfusion. As decreased tis-
sue and plasma granulocyte activities were also found, 
the effects of CH
4
 on the polymorphonuclear (PMN) 
leukocyte functions were further investigated by using 
isolated cells. The in vitro results substantiated the in 
vivo findings, and established that CH
4
 exposure specif-
ically decreases the ROS production of activated PMN 
leukocytes in a hitherto unrecognized reaction path-
way [5]. More importantly, the inhalation of 2.5% CH
4
 
decreased the signs of oxidative and nitrosative stress, 
with reduced structural damage [5].
3. Summary
In an evaluation of the role and the significance of 
CH
4
 in physiology, it seems reasonable to proceed 
via previously defined points [1]. CH
4
 has a long 
evolutionary history on Earth, but the observation that 
CH
4
 formation occurs in many hypoxic systems has 
opened up new, interesting and challenging research 
avenues. Is it a waste product or is it still bioactive? 
Figure 1. Schematic diagram of the proposed mechanisms for the oxido-reductive stress-induced abiotic 
methanogenic response. METC: mitochondrial electron transport chain, SOD: superoxide dismutase, 
ASC: ascorbic acid, DHASC: dehydroascorbic acid, Met: methionine, MetSO: methionine sulfoxide, 
MSA: methanesulfonic acid, HCyA: homocysteic acid, DMEA: N,N-dimethylethanolamine, MEA: 
N-methylethanolamine, EMG: electrophilic methyl group-containing biomolecules, MDC: methyl-donor 
compound. See [40, 52, 54] for further details.
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Various data suggest that the excretion of CH
4
 in 
the breath of mammals may predominantly reflect 
intestinal bacterial fermentation, but a variable amount 
is possibly linked to a mitochondrial dysfunction. If 
nonbacterial CH
4
 is added to the bacterial production, 
this addition could occur at a time and rate that 
is impossible to be detected by the conventional 
techniques that have thus far been utilized to look for it.
In a consideration of aerobic biotic CH
4
 genera-
tion, the origin of the emission and the underlying 
mechanisms are still not known with certainty, and the 
immediate challenge is therefore to test the proposed 
hypotheses for aerobic CH
4
 formation from differ-
ent biomolecules and cellular/tissue structures, and 
to construct a comprehensive picture of the specific 
importance of these reactions in mammals. Although 
the results presented to date establish a bioactive role 
for CH
4
, it is not obvious whether it originates from 
bacterial, external or endogenous sources. As an anal-
ogy, other gaseous compounds, such as NO, H
2
S or CO, 
were previously thought to be toxic or to be without 
effects on the function of the living aerobic organisms. 
If CH
4
 bioactivity is acknowledged, it is tempting to 
speculate that a low, but stable proportion of intrin-
sic CH
4
 is required to keep the inflammatory signals in 
resting conditions in the GI tract. Indeed, in contrast 
with other organs, the gut wall is persistently exposed to 
bacterial toxins, products of phagocytic cells and non-
bacterial antigens that cross the mucosal epithelium, 
and this presupposes the action of a system which tunes 
or modulates the constant pro-inflammatory activity. 
Hypoxic events could have additional effects in the way 
in which they enhance inflammatory activation, lead-
ing in parallel to CH
4
 generation.
Whether there is a cellular membrane ‘receptor’ 
for such events needs to be elucidated. The subcellular 
molecular targets are not known either. Thus, overall 
these data do not fully support the gasotransmitter con-
cept, but they do support the notion that CH
4
 liberation 
may be linked to redox regulation. In this respect, the 
available information suggests that hypoxia-induced 
CH
4
 generation may be a necessary phenomenon of 
aerobic life, and perhaps a surviving evolutionary trait 
in plants and animals.
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